Doctor profile · Federal record
Dr. Mark Lewis, MD
Dermatology Physician (CMS: Dermatology) · Danvers, MA
- NPI 1538262670
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 56 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
99 Conifer Hill Dr
Danvers, MA 019231193
(978) 774-2555
fax (978) 774-8715 - Mailing address
-
147 S Main St
Middleton, MA 019492446
Credentials & registration
- NPI registered
- September 2006 — 20 yrs on file
- Profile last updated
- May 21, 2025
- Year of graduation
- 1970 — 56 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Massachusetts #44331
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1538262670. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,532
Distinct HCPCS
10
Medicare allowed
$183,515
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 752 | 601 | $92 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 524 | 160 | $7 | |
17000 |
Destruction of precancer skin growth, 1 growth | 333 | 262 | $58 | |
11102 |
Biopsy of related skin growth, first growth | 224 | 204 | $100 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 163 | 141 | $58 | |
17110 |
Destruction of skin growth, 1-14 growths | 154 | 137 | $115 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 110 | 110 | $114 | |
11103 |
Biopsy of related skin growth, each additional growth | 65 | 44 | $52 | |
17262 |
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 56 | 46 | $169 | |
99202 |
New patient office or other outpatient visit, 15-29 minutes | 26 | 26 | $69 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 148. This provider delivers 17× the peer median.Open Payments
Industry payments received
All-time total
$908
Transactions
42
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, Inc. | 10 | $208.51 | |
| E.R. Squibb & Sons, L.L.C. | 10 | $147.04 | |
| ABBVIE INC. | 5 | $129.40 | |
| GENZYME CORPORATION | 3 | $90.41 | |
| PFIZER INC. | 3 | $75.98 | |
| Lilly USA, LLC | 3 | $53.73 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $52.03 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $32.47 | |
| Novartis Pharmaceuticals Corporation | 1 | $29.29 | |
| Amgen Inc. | 1 | $26.87 | |
| Sandoz Inc. | 1 | $26.56 | |
| Incyte Corporation | 1 | $21.75 | |
| UCB, Inc. | 1 | $14.35 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
620
Patients
375
Total drug cost
$20,373
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc) | Brand | 103 | 57 | $3,143 |
| Alclometasone Dipropionate | Generic | 69 | 42 | $2,580 |
| Clobetasol Propionate | Generic | 61 | 35 | $3,368 |
| Betamethasone Dipropionate | Generic | 51 | 20 | $1,778 |
| Ciclopirox (Ciclopirox Olamine) | Brand | 48 | 28 | $774 |
| Fluticasone Propionate | Generic | 46 | 26 | $999 |
| Gentamicin Sulfate | Generic | 45 | 36 | $1,490 |
| Ketoconazole | Generic | 39 | 15 | $820 |
| Triamcinolone Acetonide | Generic | 38 | 33 | $462 |
| Fluorouracil | Generic | 30 | 28 | $2,182 |
Frequently asked questions
What is Dr. Mark Lewis's medical specialty?
Dr. Mark Lewis practices Dermatology Physician in Danvers, MA.
Where does Dr. Mark Lewis practice?
Dr. Mark Lewis practices at 99 Conifer Hill Dr, Danvers, MA 019231193. Office phone: 9787742555.
What is Dr. Mark Lewis's NPI?
Dr. Mark Lewis's National Provider Identifier (NPI) is 1538262670, issued by NPPES.
Does Dr. Mark Lewis accept Medicare assignment?
Yes. Dr. Mark Lewis accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mark Lewis commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.